Innoviva, Inc. — Director's Dealing 2015

Jun 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2015-06-02

Reporting Person: Aguiar Michael W (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-02	Common Stock	F	24698	$16.68	Disposed	432653	Direct

Footnotes

F1: These shares were withheld by the Issuer to satisfy income tax withholding obligations associated with a performance stock award that vests based on the achievement of certain performance conditions over a six-year time-frame from 2011 through December 31, 2016 and continued employment.